Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

NCT04753177 is registered in ClinicalTrials.gov with Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary as lead sponsor.

NCT NCT04753177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04753177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer
Lead sponsor
Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 28, 2021
Completion date
January 28, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the neoadjuvant therapy